Home » Virus-Test Deal Struck With U.S. Firm
Virus-Test Deal Struck With U.S. Firm
April 15, 2005
British Biocell International (BBI), the Cardiff, Wales-based care diagnostics venture, announced a major distribution deal for its pioneering herpes testing technology. Focus Diagnostics, of California, has secured exclusive distribution rights in North America and Europe for BBI's new point-of-care product for herpes simplex virus (HSV) Type-2.
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct